← Back to headlines

Concerns Over Keytruda Leaks and Fake Sales in India, Merck Comments on Packaging Responsibility
Concerns are rising in India over the cancer drug Keytruda's availability, high cost, and reports of leaks and fake versions. Merck & Co has stated that healthcare facilities are responsible for the used packaging of the drug.
13 Apr, 04:17 — 13 Apr, 04:17
Sources
Showing 1 of 1 sources


